FRM
Fox Run Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,000
| Closed | -$25.4K | – | 814 |
|
|
2023
Q3 | $25.4K | Buy |
+12,000
| New | +$25.4K | 0.01% | 664 |
|
|
2023
Q1 | – | Sell |
-18,551
| Closed | -$187K | – | 745 |
|
|
2022
Q4 | $187K | Buy |
+18,551
| New | +$187K | 0.08% | 497 |
|
|
2018
Q2 | – | Sell |
-12,268
| Closed | -$120K | – | 743 |
|
|
2018
Q1 | $120K | Buy |
+12,268
| New | +$120K | 0.03% | 672 |
|